UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-K ______________________________________________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 2 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE ...

Q3 2021 Performance Highlights - Net sales increased by 13.6% to $376.8 million, compared to $331.7 million in Q3 2020[7] - Adjusted EBITDA decreased by 6.3% to approximately $120 million, with the adjusted EBITDA margin down 680 bps to 31.7%[6, 7] - Performance Materials segment was negatively impacted by depressed automotive production due to the global microchip shortage, while Engineered Polymers and Industrial Specialties showed strong growth[6] Segment Performance - Performance Chemicals sales increased by 37.7% to $258.7 million, driven by strong demand in Engineered Polymers and Industrial Specialties[10, 11] - Engineered Polymers sales increased by 109.1% to $52.9 million[11] - Industrial Specialties sales increased by 47.1% to $132.5 million[11] - Performance Materials sales decreased by 17.9% to $118.1 million due to lower automotive production[14, 15] - Performance Chemicals segment EBITDA increased by 33.7% to $63.1 million[10, 11] - Performance Materials segment EBITDA decreased by 29.9% to $56.4 million[14, 15] Financial Metrics - Free cash flow for the quarter was $75 million, enabling $32 million of share repurchases at an average price of $77.79[26] - Year-to-date share repurchases totaled $100 million (1.3 million shares) at an average price of $77.26[26] - Net debt ratio was maintained at 2.1x, within the target range of 2.0x-2.5x[26] Full Year 2021 Guidance - Revenue is projected to be between $1.32 billion and $1.36 billion[30] - Adjusted EBITDA is projected to be between $405 million and $420 million[31] - Capital expenditures are expected to be between $100 million and $115 million[32] - Free cash flow is expected to be greater than $200 million[33] - Net debt ratio is expected to be between 2.0x and 2.5x[34]

Ingevity Corporation (NYSE:NGVT) Q3 2021 Earnings Conference Call October 28, 2021 10:00 AM ET Company Participants Bill Hamilton - Treasurer & Head of Investor Relations John Fortson - President & Chief Executive Officer Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Mary Hall - Chief Financial Officer Conference Call Participants Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Vincent Anderson - Stifel Ian Zaffino - Oppenheimer. Paretosh Misra - B ...

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ For the quarterly period ended September 30, 2021 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 4920 O'Hear Avenue Suite 400 North Charleston ...

Jefferies Industrials Conference Mary Hall, Chief Financial Officer Bill Hamilton, Treasurer and Investor Relations August 4, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements m ...

Ingevity Corporation (NYSE:NGVT) Q2 2021 Earnings Conference Call July 29, 2021 10:00 AM ET Company Participants Bill Hamilton ??? Treasurer and Vice President of Investor Relations John Fortson ??? President and Chief Executive Officer Ed Woodcock ??? President of Performance Materials Mike Smith ??? President of Performance Chemicals Mary Hall ??? Chief Financial Officer Conference Call Participants John McNulty ??? BMO Capital Markets Mike Sison ??? Wells Fargo Mark Zhang ??? Oppenheimer John Tanwanteng ...

ingevity. Second Quarter 2021 Earnings Presentation July 29, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, res ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 _______________________ ...

Ingevity Corporation (NYSE:NGVT) Q1 2021 Earnings Conference Call April 29, 2021 10:00 AM ET Company Participants Bill Hamilton - Treasurer and Head of Investor Relations John Fortson - President and CEO Mike Smith - President of Performance Chemicals Ed Woodcock - President of Performance Materials Erik Ripple - Chief Growth and Innovation Officer Mary Hall - CFO Conference Call Participants John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Daniel Rizzo - Jefferies Ian Zaffino - Oppenheime ...

ingevity. First Quarter 2021 Earnings Presentation April 29, 2021 PURIFY I PROTECT I ENHANCE Disclaimer: This presentation contains "forward-looking statements" within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words "will," "plans," "intends," "targets," "expects," "outlook," or similar expressions. Forward-looking statements may include, without limitation, expected financial positions, res ...